We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
-6.78%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$259B
AUM Growth
-$23.7B
Cap. Flow
+$1.72B
Cap. Flow %
0.66%
Top 10 Hldgs %
24.75%
Holding
3,400
New
107
Increased
1,503
Reduced
1,401
Closed
139

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.2B
2
ZBRA icon
Zebra Technologies
ZBRA
+$682M
3
ADSK icon
Autodesk
ADSK
+$664M
4
ENTG icon
Entegris
ENTG
+$646M
5
NKE icon
Nike
NKE
+$560M

Sector Composition

Rank Sector Weight
1 Technology 25.99%
2 Healthcare 16.08%
3 Consumer Discretionary 12.25%
4 Financials 11.95%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRHC
3051
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$149K ﹤0.01%
25,800
-70,296
-73% -$631K
CGEM icon
3052
Cullinan Oncology
CGEM
$1.06B
$148K ﹤0.01%
14,100
-1,800
-11% -$24.3K
PRLD icon
3053
Prelude Therapeutics
PRLD
$345M
$148K ﹤0.01%
21,500
-1,968
-8% -$18K
NEUE
3054
DELISTED
NeueHealth
NEUE
$148K ﹤0.01%
960
+816
+567% +$181K
LFAC
3055
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
$148K ﹤0.01%
+14,785
New +$147K
DNZ
3056
DELISTED
D and Z Media Acquisition Corp.
DNZ
$147K ﹤0.01%
15,000
ATOS icon
3057
Atossa Therapeutics
ATOS
$24.1M
$146K ﹤0.01%
7,767
+27
+0.3% +$549
GLRE icon
3058
Greenlight Captial
GLRE
$585M
$144K ﹤0.01%
20,305
ORMP icon
3059
Oramed Pharmaceuticals
ORMP
$169M
$144K ﹤0.01%
16,700
ZYXI
3060
DELISTED
Zynex
ZYXI
$144K ﹤0.01%
23,163
-36,416
-61% -$256K
ASXC
3061
DELISTED
Asensus Surgical, Inc.
ASXC
$142K ﹤0.01%
226,900
+700
+0.3% +$539
FRBK
3062
DELISTED
Republic First Bancorp Inc
FRBK
$142K ﹤0.01%
27,500
+100
+0.4% +$481
TPC
3063
Tutor Perini Cor
TPC
$4.31B
$141K ﹤0.01%
13,095
-3,000
-19% -$33.6K
CORZW
3064
DELISTED
Core Scientific, Inc. Warrant
CORZW
$141K ﹤0.01%
75,000
FF icon
3065
Future Fuel
FF
$204M
$140K ﹤0.01%
14,368
-481
-3% -$3.91K
FMN
3066
Federated Hermes Premier Municipal Income Fund
FMN
$87M
$139K ﹤0.01%
10,946
TCRT icon
3067
Alaunos Therapeutics
TCRT
$4.59M
$139K ﹤0.01%
1,424
+5
+0.4% +$642
EIM
3068
Eaton Vance Municipal Bond Fund
EIM
$493M
$138K ﹤0.01%
11,970
EZPW icon
3069
Ezcorp Inc
EZPW
$1.83B
$136K ﹤0.01%
22,541
+144
+0.6% +$898
RNAC icon
3070
Cartesian Therapeutics
RNAC
$226M
$136K ﹤0.01%
3,690
+10
+0.3% +$626
RSVR icon
3071
Reservoir Media
RSVR
$731M
$135K ﹤0.01%
+13,766
New +$103K
CMBT
3072
CMB.TECH NV
CMBT
$4.48B
$135K ﹤0.01%
12,771
-25,752
-67% -$255K
HT
3073
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$135K ﹤0.01%
14,820
-2,049
-12% -$18.9K
ADVM
3074
DELISTED
Adverum Biotechnologies
ADVM
$134K ﹤0.01%
10,210
+40
+0.4% +$585
CTMX icon
3075
CytomX Therapeutics
CTMX
$694M
$133K ﹤0.01%
49,700
+200
+0.4% +$768

Similar funds

AllianceBernstein's Q1 2022 Portfolio in Review

As of Q1 2022, AllianceBernstein held 3,400 positions worth $259B, down 8.4% from $283B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

AllianceBernstein's Q1 2022 filing shows 107 new, 1,503 increased, 1,401 reduced and 139 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 1,823,221 shares worth $69.9M. The largest sale was Meta Platforms (Facebook), an estimated $1.47B.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AllianceBernstein's largest Q1 2022 buy was State Street Financial Select Sector SPDR ETF: 1,823,221 shares worth $69.9M.
  • AllianceBernstein added most to Advanced Micro Devices in Q1 2022, an estimated $1.2B increase.
  • AllianceBernstein's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.47B.
  • AllianceBernstein fully exited Xilinx Inc in Q1 2022, selling an estimated $1.39B.
  • AllianceBernstein's ten largest holdings make up 25% of its $259B portfolio in Q1 2022.
  • AllianceBernstein opened 107 new positions and closed 139 in Q1 2022.
  • AllianceBernstein's portfolio value fell 8.4% quarter-over-quarter to $259B.

Based on AllianceBernstein's 13F filing for Q1 2022, filed 13 May 2022.